Virax Biolabs Group Ltd
VRAX0.850USD
+0.005+0.57%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.850USD+0.850After-hours (ET)
3.69MMarket Cap
--P/E TTM
Virax Biolabs Group Ltd
0.850
+0.005+0.57%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H2
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022Q4
FY2022Q2
Total equity
Cash, cash equivalents and short-term investments
17.82%4.23M
42.64%7.29M
-61.62%3.59M
11.77%5.11M
--9.35M
--4.57M
--21.76K
--11.68K
- Cash and cash equivalents
17.82%4.23M
42.64%7.29M
-61.62%3.59M
11.77%5.11M
--9.35M
--4.57M
--21.76K
--11.68K
Receivables
-85.93%30.65K
-85.74%26.16K
--217.84K
--183.36K
----
----
--0.00
--0.00
-Accounts and notes receivable
----
--2.36K
----
----
----
----
--0.00
--0.00
Inventory
56.79%94.67K
411.08%125.25K
--60.38K
--24.51K
--0.00
--0.00
--20.95K
--21.07K
Prepaid expenses
5.19%539.38K
-9.08%595.93K
82.18%512.78K
-9.46%655.42K
--281.48K
--723.87K
--6.00K
--10.28K
Other current assets
----
----
----
----
----
--4.69K
----
----
Total current assets
11.72%4.89M
34.54%8.03M
-54.53%4.38M
12.69%5.97M
--9.63M
--5.30M
--48.71K
--43.03K
Non-current assets
Net Fixed Assets
38.92%1.53M
107.47%1.41M
--1.10M
--679.42K
----
----
----
----
-Fixed Assets
59.77%1.85M
127.99%1.59M
--1.16M
--695.27K
----
----
----
----
-Accumulated depreciation
479.24%317.83K
1007.25%175.56K
--54.87K
--15.86K
----
----
----
----
Goodwill and other intangible assets
----
----
-100.00%0.00
--374.67K
--178.40K
----
----
----
Total non-current assets
38.92%1.53M
33.73%1.41M
518.67%1.10M
--1.05M
--178.40K
----
----
----
Total assets
17.19%6.43M
34.41%9.44M
-44.11%5.48M
32.58%7.03M
--9.81M
--5.30M
--48.71K
--43.03K
Liabilities
Current liabilities
-Other payables
----
----
----
----
--0.00
--27.24K
--129.94K
--449.61K
Accrued expenses
--194.08K
40.66%303.92K
-100.00%0.00
-27.45%216.06K
--409.71K
--297.81K
----
--259.41K
Short-term debt and lease liabilities
78.21%85.46K
445.71%271.10K
-67.21%47.95K
-87.26%49.68K
--146.25K
--390.00K
----
--100.00K
-Short-term debt
--32.47K
--222.73K
-100.00%0.00
----
--146.25K
--390.00K
----
--100.00K
-Short-term lease liabilities
10.51%52.99K
-2.62%48.38K
--47.95K
--49.68K
----
----
----
----
Deferred liabilities
----
----
-100.00%0.00
----
--38.25K
----
----
----
Other current liabilities
----
----
-100.00%0.00
----
--38.25K
--27.24K
--129.94K
--449.61K
Total current liabilities
298.70%673.21K
-11.82%693.97K
-81.41%168.85K
-31.11%787.02K
--908.40K
--1.14M
--1.25M
--1.05M
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Total non-current liabilities
65.33%291.54K
151.54%332.10K
--176.34K
--132.03K
----
----
----
----
Total liabilities
179.48%964.75K
11.64%1.03M
-62.00%345.19K
-19.56%919.05K
--908.40K
--1.14M
--1.25M
--1.05M
Shareholders' equity
Common equity
68.69%4.34K
139.62%4.34K
65.32%2.57K
55.40%1.81K
--1.56K
--1.17K
--999.00
--301.00
Retained earnings
4.05%5.58M
36.12%8.56M
-41.25%5.36M
43.25%6.29M
--9.13M
--4.39M
---973.78K
---742.33K
Gains losses not affecting retained earnings
5657.56%112.33K
86.82%82.71K
215.58%1.95K
1501.19%44.27K
---1.69K
--2.77K
---1.80K
---2.34K
Non-controlling interests
-2.63%-233.97K
-0.51%-228.12K
-2.51%-227.98K
4.14%-226.95K
---222.40K
---236.76K
---222.13K
---203.74K
Total equity
6.29%5.46M
37.84%8.42M
-42.29%5.14M
46.92%6.11M
--8.90M
--4.16M
---1.20M
---1.00M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
